IO
$31.16
+0.01
(+0.03%)
As of May 26, 2026, 8:50 PM EDT
Samsara (IOT) is trading up at $31.16 (+0.03%), as of the latest quote. It operates in the sector.
IPO: December 15, 2021 · $23.00 offering · NYSE · View IPO details →
Recent News (20)
-
Form 6K Nanobiotix For: 26 May Form 6K Nanobiotix For: 26 May
-
Dana White: White House UFC event 'not at all' political UFC President and CEO Dana White says he does not consider taking his sport to the South Lawn of the White House a political decision but a patriotic one instead. "You can make anything political if y…
-
Small-Cap Stock Riot Platforms Is Surfing The A.I. Infrastructure Wave Small-Cap Stock Riot Platforms Is Surfing The A.I. Infrastructure Wave
-
Bernstein Lifts PT on Arrowhead Pharmaceuticals (ARWR) Following Biotech’s Solid Start to 2026 Bernstein Lifts PT on Arrowhead Pharmaceuticals (ARWR) Following Biotech’s Solid Start to 2026
-
Cantor Fitzgerald reiterates Artiva Biotherapeutics stock rating
Cantor Fitzgerald reiterates Artiva Biotherapeutics stock rating
-
H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy
H.C. Wainwright reiterates Oncolytics Biotech stock rating at buy
-
Oppressing women is how authoritarianism begins. So listen to what Reform is saying | Zoe Williams
We saw it when Russia jailed members of Pussy Riot, and again when the US overturned Roe v Wade: misogyny is a powerful political weapon. Let’s focus on fighting it, not ‘understanding’ it
In preparat…
-
Marriott International’s SWOT analysis: stock holds steady amid positive industry trends Marriott International’s SWOT analysis: stock holds steady amid positive industry trends
-
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026 Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
-
Kura Oncology’s SWOT analysis: biotech stock faces launch test Kura Oncology’s SWOT analysis: biotech stock faces launch test
-
This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million
-
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
-
-
-
Cytokinetics’s SWOT analysis: biotech stock faces profitability test Cytokinetics’s SWOT analysis: biotech stock faces profitability test
-
Is Riot Platforms (RIOT) the Best Aschenbrenner Stock To Buy? Is Riot Platforms (RIOT) the Best Aschenbrenner Stock To Buy?
-
-
Form 6K Nanobiotix For: 22 May Form 6K Nanobiotix For: 22 May
-
Elliott Management Exits Two Tech Stocks and Boosts Its Hewlett Packard Enterprise Stake Elliott Management Exits Two Tech Stocks and Boosts Its Hewlett Packard Enterprise Stake
-
Have no doubt: the campaign to sack Misan Harriman is part of an assault on black figures in public life | Afua Hirsch
The move against the boss of London’s Southbank Centre sends a forbidding message about who is and isn’t seen as fit to lead in UK culture
I met Tommy Robinson once. It was 10 years ago exactly, durin…